Clinical Trials Directory

Trials / Unknown

UnknownNCT01748097

Intravenous Bicarbonate To Verify The Correct Position of IV Catheters in Oncological Patients Oncological Patients Receiving Chemotherapy

Phase III Study to Assess the Utility of a New Innovative Technique Using Intravenous Bicarbonate to Verify the Correct Position of Patients Scheduled for Intravenous Bicarbonate

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators use bicarbonate injected to an intravenous line and the changes in the exhaled end-tidal carbon dioxide to verify whether the IV line is in the vein or surrounding tissue

Detailed description

The method was proved useful in previous phase I, II studies. Now the investigators move on to assess the method in a phase III study in oncological patients. each patients which will be subjected to intravenous chemotherapy will be eligible ( see also inclusion/exclusion criteria). Once consent obtained the patient will have an IV line placed. each line placed will be categorized by the clinical team into 3 categories: 1. IV in place ready to use for chemotherapy ( good blood return) 2. Doubtful position ( no blood return/ little blood return bu flushes well). 3. IV not in place. Study design Category 1. IV bicarbonate 4.2% 20 cc and NS 20 cc in a randomized fashion Category 2. same as above Category 3. No injections

Conditions

Interventions

TypeNameDescription
DRUGsodium bicarbonate 4.2%

Timeline

Start date
2012-12-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2012-12-12
Last updated
2013-01-03

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT01748097. Inclusion in this directory is not an endorsement.